Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population (Q34112490)

31 July 2017

title

Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population (English)

1 reference

31 July 2017

0 references

1 reference

Haiyong Gu

1

1 reference

31 July 2017

Wanshan Qiu

2

1 reference

31 July 2017

Ying Wan

3

1 reference

31 July 2017

Guowen Ding

4

1 reference

31 July 2017

Weifeng Tang

5

1 reference

31 July 2017

Chao Liu

6

1 reference

31 July 2017

Yijun Shi

7

1 reference

31 July 2017

Yijang Chen

8

1 reference

31 July 2017

Suocheng Chen

9

1 reference

31 July 2017

publication date

27 December 2011

1 reference

Molecular Biology Reports

31 July 2017

published in

1 reference

31 July 2017

volume

39

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

5977-5984

1 reference

Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Chk2 activates E2F-1 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

CHK2 kinase--a busy messenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1410-1

Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review).

21 January 2018

1 reference

12 December 2020

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

12 December 2020

Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation

1 reference

12 December 2020

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome

1 reference

12 December 2020

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

1 reference

12 December 2020

The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population

1 reference

12 December 2020

Cancer of the oesophagus: a global overview

1 reference

12 December 2020

Esophageal cancer: a review and update

1 reference

12 December 2020

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

1 reference

12 December 2020

10.1007/S11033-011-1410-1

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1025447457

0 references

1 reference